SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Alpha Tau Medical Ltd. is a clinical-stage oncology therapeutics company, which focuses on the research, development, and commercialization of diffusing alpha-emitters radiation therapy for the treatment of cancer. The firm is involved in the clinical trials at cancer centers with indications that include skin cancer, oral cavity cancer, breast cancer, and pancreatic cancer. The company was founded by Uzi Sofer, Yona Keisari, and Itzhak Kelson in November 2015 and is headquartered in Jerusalem, Israel.

Alpha Tau Medical Ltd

ALPHA TAU MEDICAL LTD

Alpha Tau Medical is experiencing significant momentum and investor excitement as the community anticipates critical clinical data regarding pancreatic cancer to be shared at the Digestive Disease Week conference. The stock is a primary focus for many traders who are highlighting a series of upcoming clinical milestones and trial expansions as key drivers for long-term growth.

Akanda Corp. is a cannabis cultivation, manufacturing, and distribution company, which engages in the provision of premium quality and ethically sourced medical cannabis products to patients. The company cultivates and processes natural cannabis at facilities in the Kingdom of Lesotho, Africa and intend to supply medicinal-grade cannabis biomass, cannabis flower, and cannabis concentrates to wholesalers. It also imports and sells medical cannabis-based products. The company was founded on July 16, 2021 and is headquartered in New Romney, the United Kingdom.

Akanda Corp

Akanda Corp. is experiencing a massive short squeeze driven by its extremely low float and high cost-to-borrow rates, sparking intense community speculation about potential triple-digit price levels. Investors are actively debating whether this movement is a sustainable pivot toward telecommunications infrastructure or a classic high-risk pump-and-dump scenario.

Cue Biopharma, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of immunotherapies to treat cancer and autoimmune diseases. Its products include CUE-400 series (autoimmune diseases), CUE-500 series (targeted cell depletion), and CUE-100 series (Oncology). The company was founded by Ronald D. Seidel III, Steven Almo, and Rodolfo Chaparro on December 31, 2014 and is headquartered in Boston, MA.

Cue Biopharma Inc

Cue Biopharma is trending due to a recently confirmed $7.5 million milestone payment from Boehringer Ingelheim and an upcoming R&D presentation, which have sparked heavy retail interest and speculation about the company's clinical pipeline. The community is actively debating the stock's potential for a significant squeeze against concerns surrounding dilution, a possible reverse stock split, and the company's historical volatility.

Roblox Corp. engages in the provision of online gaming services. Its platform consists of Roblox Client, Roblox Studio, and Roblox Cloud. Roblox Client is an application that allows users to explore 3D digital worlds. Roblox Studio is the toolset that allows developers and creators to build, publish, and operate 3D experiences and other content accessed with Roblox Client. Roblox Cloud includes the services and infrastructure that power the human co-experience platforms. The company was founded by Erik Cassel and David B. Baszucki in March 2004 and is headquartered in San Mateo, CA.

Roblox Corporation - Ordinary Shares - Class A

Roblox Corp.

Roblox is experiencing intense market volatility and significant downward pressure, with investors and the community debating concerns over child safety policies, user growth deceleration, and the company's long-term path to profitability. While some participants are actively shorting the stock, others view the sharp pullback as a potential accumulation opportunity for a long-term play on the platform's massive, persistent engagement.

Sandisk Corp. engages in the development, manufacture, and provision of storage devices and solutions based on NAND flash technology. Its products include solid state drives, memory cards, and USB flash drives. The company was founded on February 5, 2024 and is headquartered in Milpitas, CA.

Sandisk Corp

Sandisk is seeing intense market activity following a blowout earnings report and the announcement of a multi-billion dollar share buyback, which has sparked a battle between investors capitalizing on the companys massive growth in AI-driven NAND storage demand and those taking profits after a significant year-long rally. While some traders are expressing frustration over the volatile price action and sell-the-news dynamics, the community remains heavily focused on the company's structural pricing power and long-term supply agreements as indicators of sustained value.

iShares Trust - iShares 20+ Year Treasury Bond ETF

iShares 20+ Year Treasury Bond ETF

TLT is facing significant volatility as investors weigh the broader impact of global energy shocks, geopolitical tensions in the Middle East, and the looming transition in Federal Reserve leadership. The community is sharply divided, with traders closely monitoring the impact of persistently high oil prices and potential debt-to-GDP concerns on bond yields, while actively debating the timing of a potential rotation into duration as a hedge against inflation and economic uncertainty.

Senseonics Holdings, Inc. is a medical technology company, which engages in the development and manufacture of glucose monitoring products. Its primary product is the brand Eversense CGM (continuous glucose monitoring) including sensors, smart transmitters, and mobile applications. The company was founded on June 26, 2014 and is headquartered in Germantown, MD.

Senseonics Holdings Inc

Senseonics is facing intense volatility and negative sentiment following the announcement of an 80 million dollar common stock and pre-funded warrant offering. The community is actively debating the necessity of this dilution, with many investors expressing deep frustration over capital management, leadership performance, and the looming threat of a further reverse split.

Reddit, Inc. operates an entertainment, social networking, and news website where registered community members can submit content. The firm provides online news services where users can select and rank web content. It also offers a personalized filter on the day's story, using previous votes to determine what new things the user might like to read. The company was founded by Steven Ladd Huffman and Alexis Ohanian on June 23, 2005 and is headquartered in San Francisco, CA.

Reddit Inc. - Ordinary Shares - Class A

Reddit Inc

Reddit is trending following a significant earnings beat that surpassed top and bottom-line expectations, fueling community debate over the company's long-term monetization potential through AI data licensing. Investors and traders are actively discussing the stock's high growth trajectory and the potential for a short squeeze as they weigh these strong financials against broader market volatility.

Atlassian Corp. is a holding company, which engages in providing team collaboration and productivity software. Its products include Jira Software, Confluence, Jira Service Management, and Loom. The company was founded by Michael Cannon-Brookes and Scott Farquhar in October 2002 and is headquartered in San Francisco, CA.

Atlassian Corporation - Ordinary Shares - Class A

Atlassian Corporation Plc

Atlassian is surging following a strong quarterly earnings report that featured a beat on both top and bottom lines, fueled by cloud demand and accelerated AI adoption. While some investors remain cautious about the broader enterprise software sector, the community is actively debating whether this performance signals a genuine fundamental reversal or merely a tactical relief rally for a stock that has experienced significant year-to-date pressure.

Roku, Inc. engages in the provision of a streaming platform for television. It operates through the following segments: Platform and Devices. The Platform segment includes the sale of digital advertising and distribution of streaming services. The Devices segment is involved in the sale of streaming players, Roku-made televisions, smart home products and services, audio products, and related accessories. The company was founded by Anthony J. Wood in October 2002 and is headquartered in San Jose, CA.

Roku Inc - Ordinary Shares - Class A

Roku Inc

Roku is trending following a strong quarterly earnings report that featured a revenue beat and upward guidance, fueling community optimism about the company's path to sustainable profitability. While bulls are celebrating platform growth and the stock's potential for a major breakout, traders remain focused on whether the momentum can overcome recurring market volatility and skepticism regarding institutional positioning.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Daxor Corporation (NASDAQ:DXR) Short Interest Update

Daxor Corporation (NASDAQ:DXR - Get Free Report) saw a large growth in short interest during the month of March. As of March 13th, there was short interest totaling 9,006 shares, a growth of 149.8...

Daxor Details Portable FDA-Cleared Blood Volume Analyzer, 'Razor-and-Blades' Kit Growth at iAccess Alpha

Daxor (NASDAQ:DXR) used its presentation at the iAccess Alpha Virtual Best Ideas Spring Investment Conference 2026 to outline its focus on blood volume analysis and the company's commercialization...

Daxor (NYSEAMERICAN:DXR) Share Price Passes Below 200-Day Moving Average - Here's What Happened

Daxor (NYSEAMERICAN:DXR) Share Price Passes Below 200 Day Moving Average - Here's Why...

Short Interest in Daxor Corporation (NASDAQ:DXR) Decreases By 44.0%

Daxor Corporation (NASDAQ:DXR - Get Free Report) was the recipient of a large decrease in short interest in February. As of February 13th, there was short interest totaling 3,761 shares, a decrease...

Daxor (NYSEAMERICAN:DXR) Share Price Crosses Below Two Hundred Day Moving Average - Time to Sell?

Daxor (NYSEAMERICAN:DXR) Shares Cross Below Two Hundred Day Moving Average - Here's What Happened...

Daxor (NYSEAMERICAN:DXR) Stock Crosses Below Two Hundred Day Moving Average - Time to Sell?

Daxor (NYSEAMERICAN:DXR) Stock Crosses Below Two Hundred Day Moving Average - Time to Sell...

Daxor (NYSEAMERICAN:DXR) Stock Passes Below 200 Day Moving Average - Time to Sell?

Daxor (NYSEAMERICAN:DXR) Stock Price Passes Below Two Hundred Day Moving Average - Should You Sell...

Daxor (NASDAQ:DXR) Stock Price Up 0.6% - Time to Buy?

Daxor (NASDAQ:DXR) Trading Up 0.6% - Here's What Happened...

Daxor Corporation (NASDAQ:DXR) Sees Large Increase in Short Interest

Daxor Corporation (NASDAQ:DXR - Get Free Report) was the target of a significant increase in short interest during the month of December. As of December 31st, there was short interest totaling 8,248...

Daxor (NYSEAMERICAN:DXR) Shares Cross Above Fifty Day Moving Average - Here's What Happened

Daxor (NYSEAMERICAN:DXR) Stock Price Crosses Above 50-Day Moving Average - Should You Sell...

DAXOR Corporation is an innovative medical instrumentation and biotechnology company. DAXOR designed and developed the BVA-100 Blood Volume Analyzer. It is the first instrument approved by the FDA to provide rapid direct measurement of a patient's true blood volume. We believe that the BVA-100 Blood Volume Analyzer has the potential to transform therapy in a broad range of surgical and medical conditions. It is our goal, working in conjunction with hospitals and clinics, to achieve that possibility.   The BVA-100 is a semi-automated Blood Volume Analyzer. It is used in conjunction with a single use diagnostic kit. It is the first FDA-approved instrument to provide rapid direct measurement of a patient's blood volume.

DXR
Daxor Corp.

Feed

News

Sentiment

Fundamentals

Info

Latest DXR News

DXRDaxor Corp.